20 Years of Legislation - How Australia Has Responded to the Challenge of Regulating Genetically Modified Organisms in the Clinic.
![]() |
Text
fmed-09-883434.pdf Download (8MB) |
Item Type: | Article |
---|---|
Official URL: | https://doi.org/10.3389/fmed.2022.883434 |
Journal or Publication Title: | Frontiers in Medicine |
Volume: | 9 |
Date: | May 2022 |
Divisions: | Gene and Stem Cell Therapy |
Depositing User: | General Admin |
Identification Number: | 10.3389/fmed.2022.883434 |
ISSN: | 2296-858X |
Date Deposited: | 17 Apr 2023 00:55 |
Abstract: | •In contrast to the prior voluntary system, since 2001, gene technology in Australia has been regulated under a legislated national Gene Technology Regulatory Scheme which is administered by the Gene Technology Regulator.•The Scheme provides science-based assessment of the potential risks of gene technology to the health and safety of people and the environment.•It complements the role of the Australian Therapeutic Goods Administration which regulates all therapeutic products in Australia to ensure they are safe and effective.•Recent reforms to the Scheme contribute to, and anticipate, the continued safe development and delivery of gene-based human therapeutics in Australia as a successful model for other jurisdictions. Keywords: clinical medicine; ethics and law; gene technology; gene technology regulation; gene therapy; risk management; technological and regulatory advances. |
Creators: | Creators Email O’Sullivan, Gabrielle M. UNSPECIFIED Philips, Joshua G. UNSPECIFIED Mitchell, Heidi J. UNSPECIFIED Dornbusch, Michael UNSPECIFIED Rasko, John E. J. UNSPECIFIED |
Last Modified: | 17 Apr 2023 00:55 |
URI: | https://eprints.centenary.org.au/id/eprint/1370 |
Actions (login required)
![]() |
View Item |